Back to Authors

Sandroni, Paola

https://orcid.org/0000-0001-7618-9661

Mayo Clinic

Mayo Clinic

Citations 71

Trigeminal trophic syndrome: A rare cause of chronic facial pain and skin ulcers
Golden, Erin C., Robertson, Carrie E. , Moossy, John, Sandroni, Paola , Garza, Ivan , Golden, Erin, Robertson, Carrie E

Cephalalgia | August 22, 2014 | Volume: 35 | Issue: 7 | Pages: 636-636

10.1177/0333102414547140 Get It

Multiple system atrophy: Prognostic indicators of survival
Figueroa, Juan J., Parsaik, Ajay K. , Benarroch, Eduardo E. , Ahlskog, J. Eric , Fealey, Robert D., Parisi, Joseph E., Sandroni, Paola , Mandrekar, Jay , Iodice, Valeria , Low, Phillip A. , Bower, James H., Singer, Wolfgang

Movement Disorders | June 7, 2014 | Volume: 29 | Issue: 9 | Pages: 1151-1157

10.1002/mds.25927 Get It

AbstractNeurological and autonomic presentation in multiple system atrophy (MSA) may predict early mortality. Quantification of early autonomic failure as a mortality predictor is lacking. Early neurological and autonomic clinical features were retrospectively reviewed in 49 MSA cases (median age at onset, 56.1 years; 16 women) confirmed by autopsy at Mayo Clinic. When available, the 10‐point composite autonomic severity score derived from the autonomic reflex screen provided quantification of the degree of autonomic failure and thermoregulatory sweat test quantitated body surface anhidrosis. Symptoms at onset were autonomic in 50%, parkinsonian in 30%, and cerebellar in 20% of cases. Survival (median [95% confidence interval]) was 8.6 [6.7‐10.2] years. Survival was shorter in patients with early laboratory evidence of generalized (composite autonomic severity score ≥ 6) autonomic failure (7.0 [3.9‐9.8] vs. 9.8 [4.6‐13.8] years; P = 0.036), and early requirement of bladder catheterization (7.3 [3.1‐10.2] vs. 13.7 [8.5‐14.9] years; P = 0.003) compared with those without these clinical features. On Cox proportional analysis, prognostic indicators of shorter survival were older age at onset (hazard ratio [95% confidence interval], 1.04 [1.01‐1.08]; P = 0.03), early requirement of bladder catheterization (7.9 [1.88‐38.63]; P = 0.004), and early generalized (composite autonomic severity score ≥ 6) autonomic failure (2.8 [1.01‐9.26]; P = 0.047). Gender, phenotype, and early development of gait instability, aid‐requiring ambulation, orthostatic symptoms, neurogenic bladder, or significant anhidrosis (thermoregulatory sweat test ≥ 40%) were not indicators of shorter survival. Our data suggest that early development of severe generalized autonomic failure more than triples the risk of shorter survival in patients with MSA. © 2014 International Parkinson and Movement Disorder Society
Quantification of sweat gland volume and innervation in neuropathy: Correlation with thermoregulatory sweat testing
Loavenbruck, Adam , Wendelschaefer‐Crabbe, Gwen, Sandroni, Paola , Kennedy, William R.

Muscle & Nerve | January 22, 2014 | Volume: 50 | Issue: 4 | Pages: 528-534

10.1002/mus.24185 Get It

ABSTRACTIntroduction: No study has correlated thermoregulatory sweat testing (TST) with histopathologic study of sweat glands (SGs) and SG nerve fibers (SGNFs). Methods: We studied 10 neuropathy patients in whom anhidrosis was found by TST and 10 matched controls. Skin biopsies were taken from both anhidrotic and sweating skin and immunohistochemical staining was done for nerves and basement membrane. For each biopsy, total tissue volume, total SG volume, and total SGNF length were measured. SGNF length per biopsy volume, SG volume per biopsy volume (SG%), and SGNF length per SG volume were calculated. Results: SGNF length per biopsy volume was reduced in anhidrotic site biopsies of patients compared with controls. SG% was decreased and SGNF length per SG volume increased in patients compared with controls. Conclusions: The results suggest a concomitant loss of SG volume and SGNF length in neuropathy, with greater loss of SGNFs in anhidrotic skin, possibly exceeding collateral reinnervation. Muscle Nerve 50: 528–534, 2014
Deconditioning in patients with orthostatic intolerance
Parsaik, Ajay K. , Allison, Thomas G. , Sletten, David M., Benarroch, Eduardo E. , Low, Phillip A. , Sandroni, Paola , Singer, Wolfgang , Joyner, Michael J.

Neurology | September 20, 2012 | Volume: 79 | Issue: 14 | Pages: 1435-1439

10.1212/wnl.0b013e31826d5f95 Get It

Autonomic dysfunction in dementia with Lewy bodies
Thaisetthawatkul, Pariwat , Benarroch, Eduardo E. , Sandroni, Paola , Ferman, Tanis J. , Petersen, Ronald C. , Low, Phillip A. , Boeve, Bradley F. , Ferman, Tanis J

Neurology | May 13, 2012 | Volume: 62 | Issue: 10 | Pages: 1804-1809

10.1212/01.wnl.0000125192.69777.6d Get It

Central neuropathic itch: A new treatment option?
Sandroni, Paola

Neurology | May 13, 2012 | Volume: 59 | Issue: 5 | Pages: 778-778

10.1212/wnl.59.5.778-a Get It

Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy
Figueroa, J.J., Dyck, P. James B. , Laughlin, Ruple S. , Mercado, Joaquin A., Massie, Rami , Sandroni, Paola , Low, Phillip A.

Neurology | February 23, 2012 | Volume: 78 | Issue: 10 | Pages: 702-708

10.1212/wnl.0b013e3182494d66 Get It

A Pegylated Growth Hormone Receptor Antagonist, Pegvisomant, Does Not Enter the Brain in Humans
Veldhuis, Johannes D. , Bidlingmaier, Martin , Bailey, Joy N., Erickson, Dana , Sandroni, Paola , Bidlingmaier, Martin

The Journal of Clinical Endocrinology & Metabolism | May 6, 2010 | Volume: 95 | Issue: 8 | Pages: 3844-3847

10.1210/jc.2010-0538 Get It

Sudomotor dysfunction in autoimmune autonomic ganglionopathy
Kimpinski, Kurt , Iodice, Valeria , Sandroni, Paola , Fealey, Robert D., Vernino, Steven , Low, P. A., Vernino, Steven

Neurology | November 2, 2009 | Volume: 73 | Issue: 18 | Pages: 1501-1506

10.1212/wnl.0b013e3181bf995f Get It